Tag: paroxetine (Paxil)
Jim van Os and Peter Groot: When Assessing Antidepressant Withdrawal Methods,...
Jim van Os and Peter Groot discuss their paper: “Successful Use of Tapering Strips for Hyperbolic Reduction of Antidepressant Dose: A Cohort Study” published in the journal Therapeutic Advances in Psychopharmacology.
Wendy Dolin – Making Akathisia a Household Word
An interview with Wendy Dolin who talks about the work of MISSD, the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin, a non-profit founded to raise awareness of the tragic consequences of drug-induced akathisia.
Antidepressant Withdrawal: An Unknown Disorder?
Antidepressant withdrawal is no longer an unknown disorder since knowledge on this topic has grown enough to be translated into practice. As proposed by George Engel in 1977, medical doctors, including psychiatrists, can observe and listen to their patients and develop a program to treat withdrawal and restore health.
Stewart Dolin’s Widow Loses $3 Million Verdict for Paxil Suicide on...
From The American Lawyer: "A federal appeals court has thrown out a $3 million verdict awarded last year to the widow of a former Reed...
Stevie: Severe and Protracted Withdrawal From Paroxetine
Stevie describes her experiences taking antidepressant drugs and her severe and protracted reaction to trying to withdraw.
Tina: Medication Changes and Antidepressant Withdrawal
Tina talks about her experience with depression, her use of antidepressant drugs and how a change in her medication led to her withdrawal problems.
$3 Million Awarded to Widow who Sued Pharmaceutical Firm
From Chicago Tribune: GlaxoSmithKline must pay $3 million to the widow of a man who killed himself after taking the antidepressant paroxetine. Article →
Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.
Paxil Linked to Birth Defects, Cardiac Malformations
According to the CDC, January is National Birth Defects Prevention Month. New research continues to link various SSRI antidepressants with birth defects and neurological abnormalities in newborns. The latest study to examine this topic, a meta-analysis led by Dr. Anick Bérard, found a 23% increased risk for birth defects, and a 28% increased risk for heart problems, in the infants of women who took the SSRI Paxil (paroxetine) during their first trimester.